Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy (Q42038270)
Jump to navigation
Jump to search
scientific article published on 17 March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy |
scientific article published on 17 March 2010 |
Statements
1 reference
Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy (English)
1 reference
Hanan Amro
1 reference
Scott J Wilderman
1 reference
Yuni K Dewaraja
1 reference
Peter L Roberson
1 reference
17 March 2010
1 reference
1 reference
654-659
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference